Two-pronged Antibody Can Help Efficiently Destroy Ovarian Cancer Cells, Researchers Find

Two-pronged Antibody Can Help Efficiently Destroy Ovarian Cancer Cells, Researchers Find
A newly developed two-pronged antibody is 100 times more effective at destroying ovarian cancer cells than other antibodies in clinical trials, according to researchers at the University of Virginia School of Medicine. Their study, “A Single-Agent Dual-Specificity Targeting of FOLR1 and DR5 as an Effective Strategy for Ovarian Cancer,” was published in the journal Cancer

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *